Insights

Innovative Oncology Focus Orion Pharma's strong emphasis on oncology research and the development of investigational drugs like ODM-212 presents significant opportunities to collaborate on advanced cancer therapies, catering to growing market demand for targeted treatments.

Expansion and Sustainability Recent facility expansions in Turku, including carbon-neutral production processes, highlight Orion's commitment to sustainable manufacturing, opening avenues for eco-conscious partners and suppliers aligned with green initiatives.

Strategic Collaborations Partnerships such as the one with Bayer for prostate cancer medications demonstrate Orion's openness to joint ventures, providing potential pathways for co-development and co-marketing of innovative pharmaceuticals.

Global Market Presence With a substantial workforce and international operations, including recent investments in South Korea, Orion is well-positioned to leverage new markets and distribute pharmaceutical products widely, expanding sales channels.

Focus on Lifesaving Drugs Active development and collaboration in creating lifesaving medicines signal opportunities to introduce essential treatments to healthcare providers seeking advanced solutions in critical care areas.

Orion Pharma Tech Stack

Orion Pharma uses 8 technology products and services including Amazon Web Services, ISO/IEC 27001, Microsoft Active Directory, and more. Explore Orion Pharma's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • ISO/IEC 27001
    Governance, Risk And Compliance
  • Microsoft Active Directory
    Identity And Access Management
  • Honeywell
    IT Infrastructure
  • Veeva Systems
    IT Infrastructure & Operations Management
  • Microsoft Windows
    Operating Systems
  • Harri
    Time Tracking
  • Piwik PRO Core
    Web Analytics

Media & News

Orion Pharma's Email Address Formats

Orion Pharma uses at least 2 format(s):
Orion Pharma Email FormatsExamplePercentage
First.Last@orion.fiJohn.Doe@orion.fi
97%
Last.First@orion.fiDoe.John@orion.fi
2%
FirstL@orion.fiJohnD@orion.fi
1%
First.Last@orionpharma.comJohn.Doe@orionpharma.com
98%
Last@orionpharma.comDoe@orionpharma.com
1%
First.MiddleLast@orionpharma.comJohn.MichaelDoe@orionpharma.com
1%

Frequently Asked Questions

What is Orion Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Orion Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Orion Pharma's stock symbol?

Minus sign iconPlus sign icon
Orion Pharma is a publicly traded company; the company's stock symbol is ONL.

What is Orion Pharma's official website and social media links?

Minus sign iconPlus sign icon
Orion Pharma's official website is orionpharma.com and has social profiles on LinkedIn.

What is Orion Pharma's SIC code NAICS code?

Minus sign iconPlus sign icon
Orion Pharma's SIC code is 6531 - Real Estate Agents and Managers NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Orion Pharma have currently?

Minus sign iconPlus sign icon
As of July 2026, Orion Pharma has approximately 3.5K employees across 6 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officer: Y. S.Cio: S. M.Chief Medical Officer, Head Of Global Medical Affairs: P. R.. Explore Orion Pharma's employee directory with LeadIQ.

What industry does Orion Pharma belong to?

Minus sign iconPlus sign icon
Orion Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does Orion Pharma use?

Minus sign iconPlus sign icon
Orion Pharma's tech stack includes Amazon Web ServicesISO/IEC 27001Microsoft Active DirectoryHoneywellVeeva SystemsMicrosoft WindowsHarriPiwik PRO Core.

What is Orion Pharma's email format?

Minus sign iconPlus sign icon
Orion Pharma's email format typically follows the pattern of First.Last@orion.fi. Find more Orion Pharma email formats with LeadIQ.
Orion Pharma logo

Orion Pharma

Pharmaceutical ManufacturingUusimaa, Finland1001-5000 Employees

Orion Corporation is a Nordic pharmaceutical company with a global footprint, focused on developing, manufacturing, and marketing medicines for humans and animals, as well as active pharmaceutical ingredients. Its portfolio comprises both proprietary and generic medicines and consumer health products, reflecting a diversified range of offerings. The company's R&D emphasizes oncology and pain, with proprietary therapies directed at cancer, respiratory, and neurological diseases. Based in Espoo, Uusimaa, Finland, Orion traces its operations to a long history in the sector, spanning more than a century.

It serves international markets by bringing its products from development to distribution with a sizable global workforce. In 2026 it announced a collaboration with Bayer AG to develop Nubeqa, a prostate cancer drug, and expanded its Turku facilities to advance carbon-free production.

Section iconCompany Overview

Phone number
SIC Code
6531 - Real Estate Agents and Managers
Stock Symbol
ONL
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $1B$10B

    Orion Pharma's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    Orion Pharma's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.